Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Benlysta® (belimumab) – New indication
On December 17, 2020 - GlaxoSmithKline announced the FDA approval of Benlysta (belimumab), for the treatment of adult patients with active lupus nephritis who are receiving standard therapy.
